ResQ Pharma CEO Paul Burton has big plans

He’s seeking regulatory approval for his pharmaceutical company’s lipid emulsion resuscitation therapy (LRT) in global markets. Posted May 3, 2017 By Clayton Gentry MATTER Journalism Fellow By most people’s standards, Paul Burton has done it all. He conducted research in the University of Illinois at Chicago’s pharmacology department, served in the US Army during the […]



MATTER Turns Two

Posted March 20, 2017 By Steven Collens MATTER CEO Two years ago, we opened MATTER with the goal of creating a better way to bring healthcare technology solutions to market. We now work with 200 healthcare startup companies – ranging from those that are barely more than ideas, to companies with millions of dollars of […]